<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02495675</url>
  </required_header>
  <id_info>
    <org_study_id>IUCPQ-HDWOBSS</org_study_id>
    <nct_id>NCT02495675</nct_id>
  </id_info>
  <brief_title>Effects of Treatment With High Flow Nasal Cannulas on Respiratory Pattern and Work of Breathing Among Healthy Subjects</brief_title>
  <acronym>HDWOBSS</acronym>
  <official_title>Effects of Treatment With High Flow Nasal Cannulas on Respiratory Pattern and Work of Breathing Among Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laval University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the work of breathing among healthy subjects under various conditions of
      treatment with high flow nasal cannulas. Ten subjects will be included. The design of this
      study is a cross over of five treatment periods with different flow settings.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      High flow oxygen therapy (HFOT) is a promising technique increasingly used in the management
      of acute respiratory failure. In hospitalised hypoxemic patients, recent clinical evidence
      showed that HFOT can reduce endotracheal intubation and reduce mortality. Physiologically,
      the HFOT causes a decrease in respiratory rate and minute-ventilation and may be associated
      with a decrease in carbone dioxyde arterial pressure. It is possible that these effects are
      associated with decreased work of breathing, which could explain some of the benefits in
      terms of comfort and efficiency.

      The objective of this research is to evaluate the impact of a wash-out of anatomical dead
      space by high flow nasal cannulas on respiratory parameters and on the work of breathing
      among healthy subjects. The investigators will evaluate the baseline status in room air, and
      then compare it with four different levels of flow. The primary endpoint will be the work of
      breathing.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2015</start_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Work of breathing</measure>
    <time_frame>10 minutes</time_frame>
    <description>Work of breathing at the end of each period is calculated from the measurement of esophageal pressure and tidal volume (composite outcome).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Esophageal pressure-time product</measure>
    <time_frame>10 minutes</time_frame>
    <description>Measured at the end of each period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tidal Volume</measure>
    <time_frame>10 minutes</time_frame>
    <description>Measured at the end of each period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comfort of breathing</measure>
    <time_frame>10 minutes</time_frame>
    <description>Subjective evaluation at the end of each period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood gases</measure>
    <time_frame>10 minutes</time_frame>
    <description>Arterial or capillary blood gases at the end of each period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea</measure>
    <time_frame>10 minutes</time_frame>
    <description>Evaluation on a borg scale at the end of each period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Rate</measure>
    <time_frame>10 minutes</time_frame>
    <description>Measured at the end of each period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>End-tidal carbon dioxide</measure>
    <time_frame>10 minutes</time_frame>
    <description>Measured at the end of each period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>10 minutes</time_frame>
    <description>Measured at the end of each period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen saturation</measure>
    <time_frame>10 minutes</time_frame>
    <description>Measured at the end of each period</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>No flow</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects will be spontaneously breathing in room air with no flow.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional flow via nasal prongs</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be breathing with nasal prongs delivering 5 L/min of air (inspired fraction of oxygen: 0.21)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High flow nasal cannulas 20 L/min</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be breathing with high flow nasal cannulas delivering 20 L/min with an inspired fraction of oxygen of 0.21.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High flow nasal cannulas 40 L/min</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be breathing with high flow nasal cannulas delivering 40 L/min with an inspired fraction of oxygen of 0.21.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High flow nasal cannulas 60 L/min</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be breathing with high flow nasal cannulas delivering 60 L/min with an inspired fraction of oxygen of 0.21.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>High flow nasal cannulas</intervention_name>
    <description>Comparison of different flow levels</description>
    <arm_group_label>High flow nasal cannulas 20 L/min</arm_group_label>
    <arm_group_label>High flow nasal cannulas 40 L/min</arm_group_label>
    <arm_group_label>High flow nasal cannulas 60 L/min</arm_group_label>
    <other_name>Airvo 2; Ficher and Paykel HealthCare</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conventional flow via nasal prongs</intervention_name>
    <description>Low flow of air delivered through conventional nasal prongs</description>
    <arm_group_label>Conventional flow via nasal prongs</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy subjects

          -  Written and informed consent

        Exclusion Criteria:

          -  Pregnant or breastfeeding women;

          -  Subject enrolled in another study excluding co-enrolment;

          -  Cardio-vascular or respiratory disease;

          -  History of ear nose and throat disease (i.e. surgery, epistaxis, trauma), eso-gastric
             disease (i.e. esophageal varices, digestive haemorrhage), rheumatologic or neurologic
             disease possibly interfering with the design of the study;

          -  Subject feeling nauseous or under recent fed condition (&lt;1h).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>François Lellouche, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>IUCPQ</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mathieu Delorme, PT, MSc</last_name>
    <phone>418-656-8711</phone>
    <phone_ext>3508</phone_ext>
    <email>mathieu.delorme.2@ulaval.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>François Lellouche, MD, PhD</last_name>
    <phone>418-656-8711</phone>
    <phone_ext>3298</phone_ext>
    <email>francois.lellouche@criucpq.ulaval.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre de Recherche de l'IUCPQ</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1V4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François Lellouche, MD, PhD</last_name>
      <phone>418-656-8711</phone>
      <phone_ext>3298</phone_ext>
      <email>francois.lellouche@criucpq.ulaval.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 4, 2015</study_first_submitted>
  <study_first_submitted_qc>July 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2015</study_first_posted>
  <last_update_submitted>July 10, 2015</last_update_submitted>
  <last_update_submitted_qc>July 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 13, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

